De Mota N, Lenkei Z, Llorens-Cortès C
Institut National de la Santé et de la Recherche Médicale, Unité 36, Collège de France, Chaire de Médecine Expérimentale, Paris, France.
Neuroendocrinology. 2000 Dec;72(6):400-7. doi: 10.1159/000054609.
The peptide apelin, recently isolated from bovine stomach tissue extracts, has been identified as an endogenous ligand of the human putative receptor protein related to the angiotensin receptor AT(1) (APJ). In this article, we report cloning of the rat apelin receptor cDNA. The sequence shares 90% identity with the human APJ receptor and 31% with the rat AT(1A) angiotensin receptor. Subsequently a stable CHO cell line expressing the receptor fused at its C-terminal part with the enhanced green fluorescent protein (EGFP) was established, allowing to verify its cell surface distribution and to determine the affinity of various apelin and angiotensin fragments on the cloned receptor. As shown for the human APJ receptor, the rat apelin receptor expressed in the cell line was negatively coupled to adenylate cyclase. The apelin fragment K17F (Lys(1)-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe(17)) inhibited forskolin-stimulated cAMP production at sub-nanomolar concentrations whereas angiotensin II and angiotensin III were inactive. N-terminal elongation of K17F with a tyrosine or the N-terminal deletion of the first four amino acids did not modify the inhibitory action of K17F on cAMP production. In contrast, deletion of the first seven amino acids of K17F or substitution of phenylalanine by an alanine residue at the C-terminus completely abolished the activity of the peptide. In situ hybridization analysis of apelin receptor mRNA expression in the adult rat brain showed intense labeling in the hypothalamus, especially in the supraoptic and the paraventricular nuclei. The anterior and intermediate lobes of the pituitary were also highly labeled, as well as the pineal gland. Labeling was also found in extrahypothalamic structures such as the piriform cortex, the nucleus of the lateral olfactory tract, the central grey matter, the pars compacta of the substantia nigra, the dorsal raphe nucleus, the entorhinal cortex, the dentate gyrus and the Ammon's horn. The hypothalamic and hypophyseal distribution of the receptor suggests an involvement of apelin in the control of neuro- and adenohypophyseal hormone release, whereas its presence in the pineal gland and in discrete higher brain structures points out to possible roles in the regulation of circadian rhythms and of water and food intake behavior.
肽apelin最近从牛胃组织提取物中分离出来,已被鉴定为与血管紧张素受体AT(1)(APJ)相关的人类假定受体蛋白的内源性配体。在本文中,我们报告了大鼠apelin受体cDNA的克隆。该序列与人类APJ受体有90%的同一性,与大鼠AT(1A)血管紧张素受体有31%的同一性。随后建立了一个稳定的CHO细胞系,该细胞系表达在其C末端与增强型绿色荧光蛋白(EGFP)融合的受体,从而能够验证其细胞表面分布,并确定各种apelin和血管紧张素片段对克隆受体的亲和力。正如人类APJ受体所示,在细胞系中表达的大鼠apelin受体与腺苷酸环化酶呈负偶联。apelin片段K17F(Lys(1)-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe(17))在亚纳摩尔浓度下抑制福斯可林刺激的cAMP产生,而血管紧张素II和血管紧张素III则无活性。用酪氨酸对K17F进行N末端延伸或删除前四个氨基酸的N末端并不改变K17F对cAMP产生的抑制作用。相反,删除K17F的前七个氨基酸或在C末端用丙氨酸残基取代苯丙氨酸完全消除了该肽的活性。成年大鼠脑中apelin受体mRNA表达的原位杂交分析显示,下丘脑有强烈的标记,特别是在视上核和室旁核。垂体的前叶和中叶也有高度标记,松果体也是如此。在梨状皮质、外侧嗅束核、中央灰质、黑质致密部、中缝背核、内嗅皮质、齿状回和海马等下丘脑外结构中也发现了标记。受体在下丘脑和垂体的分布表明apelin参与了神经垂体和腺垂体激素释放的控制,而其在松果体和离散的高级脑结构中的存在指出了其在昼夜节律调节以及水和食物摄入行为调节中的可能作用。